Resistance of follicular lymphoma cells to chemotherapy is more than just Bcl-2

Cancer Biology and Therapy

Volumn 2, Issue 5, 2003, Pages 541-543

  Hersey, Peter ^a   Zhang, Xu Dong ^a  

^a NONE

Author keywords

Apoptosis; Bcl 2; Caspase; Chemotherapy; DR5; Follicular lymphoma; p53; TRAIL

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; ETOPOSIDE; PROTEIN BCL 2; PROTEIN P53; TNFRSF10B PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

APOPTOSIS; DNA DAMAGE; DRUG EFFECT; DRUG RESISTANCE; FOLLICULAR LYMPHOMA; HUMAN; METABOLISM; NOTE; PATHOLOGY; PHYSIOLOGY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASES; DNA DAMAGE; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; HUMANS; LYMPHOMA, FOLLICULAR; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR SUPPRESSOR PROTEIN P53;

EID: 1542787628     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.2.5.543     Document Type: Note

References (30)

1. Schmitt CA, Lowe SW. Apoptosis is critical for drug response in vivo. Drug Resist Updat 2001; 4:132-4. (Pubitemid 32619571)
2. Soengas MS, Lowe SW. Apoptosis and melanoma chemoresistance. Oncogene 2003; 22:3138-51. (Pubitemid 36713766)
3. Ferreira CG, Epping M, Kruyt FAE, Giaccone G . Apoptosis: Target of cancer therapy. Clin Cancer Res 2002; 8:2024-34. (Pubitemid 34753570)
4. Green DR, Evan GI. A matter of life and death. Cancer Cell 2002; 1:19-30. (Pubitemid 41039172)
5. Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2002; 2:647-56. (Pubitemid 37328916)
6. Hersey P, Zhang XD. How melanoma cells evade TRAIL-induced apoptosis. Nat Rev 2001; 1:142-50. (Pubitemid 33741889)
7. Hersey P, Zhang XD. Overcoming resistance of cancer cells to apoptosis. J Cell Physiol 2003; 196:9-18. (Pubitemid 36676439)
8. Puthalakath H, Strasser A. Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ 2002; 9:505-12. (Pubitemid 34521178)
9. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001; 292:624-6.
10. Tsujimoto Y, Cossman J, Jaffe E, Croce C. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985; 228:1440-3. (Pubitemid 15041322)
11. Ashkenazi A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer 2002; 2:420-30. (Pubitemid 37328939)
12. Zhao S, Asgary Z, Wang Y, Goodwin R, Andreeff M, Younes A. Functional expression of TRAIL by lymphoid and myeloid tumour cells. Br J Haematol 1999; 106:827-32. (Pubitemid 29434230)
13. Thomas WD, Hersey P. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas Ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells. J Immunol 1998; 161:2195-200. (Pubitemid 28397029)
14. Nguyen T, Thomas W, Zhang XD, Gray C, Hersey P. Immunologically-mediated tumour cell apoptosis: the role of TRAIL in T cell and cytokine-mediated responses to melanoma. Forum (Genova) 2000; 10:243-52. (Pubitemid 32060873)
15. Griffith TS, Wiley SR, Kubin MZ, Sedger LM, Maliszewski CR, Fanger NA. Monocytemediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL. J Exp Med 1999; 189:1343-53. (Pubitemid 29198271)
16. Kayagaki N, Yamaguchi N, Nakayama M, Eto H, Okumura K, Yagita H. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs. J Exp Med 1999; 189:1451-60. (Pubitemid 29227531)
17. Sheikh MS, Burns TF, Huang Y, Wu GS, Amundson S, Brooks KS, et al. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha. Cancer Res 1998; 58:1593-8. (Pubitemid 28215076)
18. Takimoto R, El-Deiry WS. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site. Oncogene 2000; 19:1735-43. (Pubitemid 30200979)
19. Meng RD, El-Deiry WS. p53-independent upregulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferon-gamma. Experimental Cell Research 2001; 262:154-69. (Pubitemid 32980255)
20. Eggert A, Grotzer MA, Zuzak TJ, Wiewrodt BR , Ikegaki N, Brodeur GM. Resistance to TRAIL-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. Med Pediatr Oncol 2000; 35:603-7.
21. Fleming JB, Minna JD. Inactivation of tumor suppressor genes by promoter methylation is important in the pathogenesis of pancreatic cancer. Cancer Biol Ther 2002; 1:297-9.
22. Guo F, Bhalla K. The FLIP variation on the TRAIL DISC. Cancer Biology & Therapy 2002; 1:528-9.
23. Kelly MM, Hoel BD, Voelkel-Johnson C. Doxorubicin pretreatment sensitizes prostate cancer cell lines to TRAIL induced apoptosis which correlates with the loss of c-FLIP expression. Cancer Biology & Therapy 2002; 1:520-7.
24. Micheau O, Lens S, Gaide O, Alevizopoulos K, Tschopp J. NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol 2001; 21:5299-305. (Pubitemid 32702435)
25. Panka DJ, Mano T, Suhara T, Walsh K, Mier JW. Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells. J Biol Chem 2001; 6:6893-6.
26. Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. The EMBO J 1998; 17 :2215-23. (Pubitemid 28171907)
27. Verhagen AM, Coulson EJ, Vaux DL. Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs. Genome Biol 2001; 2:3009.1-3009.10.
28. Rothe M, Pan MG, Henzel WJ, Ayres TM, Goeddel DV. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 1995; 83:1243-52. (Pubitemid 26007814)
29. Zhang XD, Zhang XY, Gray CP, Nguyen T, Hersey P. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by Smac/DIABLO release from mitochondria. Cancer Res 2001; 61:7339-48. (Pubitemid 32946534)
30. Holcik M, Gibson H, Korneluk RG. XIAP: Apoptotic brake and promising therapeutic target. Apoptosis 2001; 6:253-61. (Pubitemid 32708519)